Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II study of intravenous versus oral ibandronate in elderly patients with bone metastases from solid tumors
2005-002802-48Phase 2Terminated
- Sponsor
- Roche
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ibandronate in bone metastases (2 arms), sponsored by Roche. Primary endpoint: Pain response. Started Jul 2007; status: terminated.
02
Drugs
ibandronate
03
Conditions
bone metastases
Beyond the preview
Go deeper on 2005-002802-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002802-48.